Finding Predictors of Side Effects to Chemoradiation Treatment in Elderly Patients With Head and Neck Cancer
Completed
Conditions studied: Head and Neck Cancer
In brief
To look at what types of measures can be used to predict how an older person will tolerate chemoradiation treatment for head and neck cancer. This study uses surveys and a blood draw to look at the different measures.
Key facts
- Study ID
- NCT01688323
- Run by
- UNC Lineberger Comprehensive Cancer Center
- People needed
- 3
- Starts
- 2012-07-01
- Expected to finish
- 2016-05-01
- Last updated by the study team
- 2017-09-12
Who can join
Age: 65 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients will be eligible for this protocol provided they have an appointment at the North Carolina Cancer Hospital (NCCH), have planned chemoradiotherapy for head and neck cancer (any histology) and consent to complete the Geriatric Assessment. No exclusions will be made based on gender, ethnicity, performance status or race. Patient must be able to read and speak English.
- Signed, IRB approved written informed consent.
- Age of at least 65 years.
- Enrollment in other studies, both therapeutic and observational, will not result in exclusion.
You may not qualify if…
- Inability to read and speak English.
- Inability to comply with study for any other reason than language
Where it is running
- UNC Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.